OCRL Antikörper (Center)
-
- Target Alle OCRL Antikörper anzeigen
- OCRL (Oculocerebrorenal Syndrome of Lowe (OCRL))
-
Bindungsspezifität
- Center
-
Reaktivität
- Human
-
Wirt
- Kaninchen
-
Klonalität
- Polyklonal
-
Konjugat
- Dieser OCRL Antikörper ist unkonjugiert
-
Applikation
- Western Blotting (WB)
- Spezifität
- Recognizes endogenous levels of OCRL protein
- Kreuzreaktivität (Details)
- Monkey
- Produktmerkmale
- Purified Polyclonal OCRL antibody
- Aufreinigung
- OCRL antibody was purified by immunogen affinity chromatography
- Immunogen
- OCRL antibody was raised in Rabbit using a KLH-conjugated synthetic peptide encompassing a sequence within the center region of human OCRL as the immunogen
- Top Product
- Discover our top product OCRL Primärantikörper
-
anti-Oculocerebrorenal Syndrome of Lowe (OCRL) (AA 146-239) antibody
OCRL Reaktivität: Human WB, ELISA, IHC (p), RNAi Wirt: Maus Monoclonal 4A6 unconjugated
anti-Oculocerebrorenal Syndrome of Lowe (OCRL) (C-Term) antibodyOCRL Reaktivität: Human WB, IHC (p), ICC, IF Wirt: Kaninchen Polyclonal unconjugated
anti-Oculocerebrorenal Syndrome of Lowe (OCRL) (AA 146-240) antibodyOCRL Reaktivität: Human WB, IHC (p), EIA Wirt: Maus Monoclonal 4A6 unconjugated
anti-Oculocerebrorenal Syndrome of Lowe (OCRL) (AA 121-271) antibodyOCRL Reaktivität: Human ELISA, IHC Wirt: Kaninchen Polyclonal unconjugated
anti-Oculocerebrorenal Syndrome of Lowe (OCRL) (AA 146-240) antibodyOCRL Reaktivität: Human WB, ELISA, IHC, IHC (p) Wirt: Maus Monoclonal 4A6 unconjugated
anti-Oculocerebrorenal Syndrome of Lowe (OCRL) (Internal Region) antibodyOCRL Reaktivität: Human, Maus WB, ELISA Wirt: Kaninchen Polyclonal unconjugated
anti-Oculocerebrorenal Syndrome of Lowe (OCRL) antibodyOCRL Reaktivität: Human, Maus, Ratte WB Wirt: Kaninchen Polyclonal unconjugated
anti-Oculocerebrorenal Syndrome of Lowe (OCRL) (AA 1-893) antibodyOCRL Reaktivität: Human WB Wirt: Kaninchen Polyclonal unconjugated
anti-Oculocerebrorenal Syndrome of Lowe (OCRL) (AA 1-893) antibodyOCRL Reaktivität: Human WB Wirt: Maus Polyclonal unconjugated
anti-Oculocerebrorenal Syndrome of Lowe (OCRL) (C-Term) antibodyOCRL Reaktivität: Human, Maus WB, ELISA, IHC Wirt: Kaninchen Polyclonal unconjugated
-
- Applikationshinweise
- WB: 1:500 - 1:1000
- Beschränkungen
- Nur für Forschungszwecke einsetzbar
-
- Format
- Liquid
- Buffer
- Supplied in liquid form in 0.42 % Potassium phosphate, 0.87 % Sodium chloride, pH 7.3 with 30 % glycerol and 0.01 % sodium azide
- Konservierungsmittel
- Sodium azide
- Vorsichtsmaßnahmen
- This product contains Sodium azide: a POISONOUS AND HAZARDOUS SUBSTANCE which should be handled by trained staff only.
- Lagerung
- 4 °C/-20 °C
- Informationen zur Lagerung
- Store at 4 deg C for short term storage. For long term, aliquot and store at -20 deg C. Avoid repeat freeze/thaw cycles
-
- Target
- OCRL (Oculocerebrorenal Syndrome of Lowe (OCRL))
- Andere Bezeichnung
- OCRL (OCRL Produkte)
- Synonyme
- OCRL antikoerper, wu:fi09g03 antikoerper, zgc:152864 antikoerper, locr antikoerper, nphl2 antikoerper, ocrl1 antikoerper, inpp5f antikoerper, INPP5F antikoerper, LOCR antikoerper, NPHL2 antikoerper, OCRL-1 antikoerper, OCRL1 antikoerper, 9530014D17Rik antikoerper, BB143339 antikoerper, OCRL, inositol polyphosphate-5-phosphatase antikoerper, phosphatidylinositol polyphosphate 5-phosphatase antikoerper, oculocerebrorenal syndrome of Lowe antikoerper, Ocrl antikoerper, NAEGRDRAFT_58601 antikoerper, OCRL antikoerper, ocrl antikoerper
- Pathways
- Inositol Metabolic Process
-
